Evidence map›Paper›PMID 33445655›Full record

ArticleDermatopathology (Basel, Switzerland)2021

Atypical Fibroxanthoma-Like Amelanotic Melanoma: A Diagnostic Challenge.

Gerardo Cazzato, Anna Colagrande, Antonella Cimmino, Giovanni Liguori, Teresa Lettini, Gabriella Serio, Giuseppe Ingravallo, Andrea Marzullo

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatopathology (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Granular Cell Dermatofibroma: When Morphology Still Matters.Dermatopathology (Basel, Switzerland) · 2021
    Article
  3. Review
  4. Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series.Cancer control : journal of the Moffitt Cancer Center
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gerardo CazzatoSection of Pathology, Department of Emergency and Organ Transplantation, University of Bari, 70121 Bari, Italy.ORCID 0000-0003-0325-4316
Anna ColagrandeSection of Pathology, Department of Emergency and Organ Transplantation, University of Bari, 70121 Bari, Italy.
Antonella CimminoSection of Pathology, Department of Emergency and Organ Transplantation, University of Bari, 70121 Bari, Italy.
Giovanni LiguoriSection of Dermatology, Department of Biomedical Science and Human Oncology, University of Bari, 70121 Bari, Italy.
Teresa LettiniSection of Pathology, Department of Emergency and Organ Transplantation, University of Bari, 70121 Bari, Italy.
Gabriella SerioSection of Pathology, Department of Emergency and Organ Transplantation, University of Bari, 70121 Bari, Italy.ORCID 0000-0001-9021-4560
Giuseppe IngravalloSection of Pathology, Department of Emergency and Organ Transplantation, University of Bari, 70121 Bari, Italy.ORCID 0000-0002-4792-3545
Andrea MarzulloSection of Pathology, Department of Emergency and Organ Transplantation, University of Bari, 70121 Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atypical fibroxanthoma-like amelanotic melanoma is a very rare variant of melanoma that can, if not correctly recognized and framed, lead to diagnostic errors that can potentially cause problems of extreme relevance to patients. Correct knowledge of this entity and the execution of adequate immunohistochemical investigations are the basic conditions for the correct management of this lesion. We report on a case of atypical fibroxanthoma-like amelanotic melanoma, which clinically simulated a fibrohistiocytic lesion, and which created differential diagnostic problems, and finally, we conduct a short review of the literature.

Indexed as

fibroxanthomamelanomaneoplasmskin

Identifiers

PMID33445655
PMCPMC7838949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.